Why is Rossari Biotech falling/rising?

As of 29-Aug, Rossari Biotech Ltd is currently priced at 618.10, reflecting an increase of 1.1 (0.18%). The stock has shown a trend reversal, gaining after four consecutive days of decline, although it is still trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has underperformed the benchmark, with a return of -2.20% compared to the Sensex's -1.84%. Additionally, the stock has seen a significant drop in delivery volume, falling by 31.07% against the 5-day average, indicating a decrease in investor participation. Despite a low debt-to-equity ratio and attractive valuation metrics, the stock has consistently underperformed, with a return of -31.32% over the past year, while profits have also declined slightly by 1%.
In the broader market context, Rossari Biotech's performance has lagged behind the Sensex, which has shown a positive return of 2.14% year-to-date, contrasting sharply with the stock's -21.53% return. The consistent underperformance against the benchmark over the last three years, coupled with flat results in June, raises concerns among investors. High institutional holdings at 21.32% may provide some support, as these investors typically have better analytical capabilities. However, the overall sentiment remains cautious due to the stock's historical underperformance and declining profitability, which could contribute to continued volatility in its price movement.